Impact of biologic class and treatment line on psoriatic arthritis risk in psoriasis: a population-based cohort study
Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence suggests that biologic therapies may differentially influence the development of PsA; however, there are no data on the relative ability of second-line biological therapy to prev...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
2026-05-01
|
| Schriftenreihe: | RMD Open |
| Online-Zugang: | https://rmdopen.bmj.com/content/12/2/e006687.full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
